This pilot study shows that prior SARS-CoV-2 exposure modulates dengue pathogenesis in a Mexican cohort, as proteomic profiling of 279 high-confidence proteins revealed enriched complement/coagulation cascades and TGF-β signaling in dual-seropositive patients. Here, TGFB1 is linked to dengue disease.